Figure 3.
Controlled LN after LN-SIB. Case of a patient receiving a LN-SIB to a remaining sLN in Level I. FDG-PET/CT imaging after 36 months shows regression without signs of recurrence within the lymphatic drainage system. *Dose 58.8 Gy in 28 Fx.
Controlled LN after LN-SIB. Case of a patient receiving a LN-SIB to a remaining sLN in Level I. FDG-PET/CT imaging after 36 months shows regression without signs of recurrence within the lymphatic drainage system. *Dose 58.8 Gy in 28 Fx.